Karuna Therapeutics
Clinical trials sponsored by Karuna Therapeutics, explained in plain language.
-
Year-Long trial tests new schizophrenia Drug's staying power
Disease control CompletedThis study aimed to see if a new drug called KarXT is safe and effective for long-term use in people with schizophrenia. Over 500 adults who were starting a new treatment took the drug for up to one year. Researchers closely monitored side effects and whether the drug helped cont…
Phase: PHASE3 • Sponsor: Karuna Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug shows promise for controlling severe schizophrenia symptoms
Disease control CompletedThis study tested a medication called KarXT for adults in China who were hospitalized due to a severe worsening of schizophrenia symptoms. For the first 5 weeks, some participants received the drug while others received a placebo, and neither they nor their doctors knew which. Th…
Phase: PHASE3 • Sponsor: Karuna Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Scientists test new mental health drug's safety with common treatments
Knowledge-focused CompletedThis early-stage study tested how a new schizophrenia drug called KarXT interacts with three common mood medications (lithium, valproic acid, and lamotrigine). Researchers gave healthy volunteers different combinations of these drugs to see how they affect each other in the body.…
Phase: PHASE1 • Sponsor: Karuna Therapeutics • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC